A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks ...

Leafy greens have had a checkered past in terms of food safety — it’s been suspected that pre-harvest irrigation water may ...

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...

An attorney for Harris County, Texas, recently filed a lawsuit against a local utility after learning that E. coli was detected in the city waterways at 1,000 times the legal limit. Newsweek reached ...

French pharma major Sanofi’s saw its shares edge up 1% by early afternoon, despite announcing a disappointment for a vaccine ...

Rand Water also emphasised that the distributed water remains safe for human consumption as it is drawn directly from the ...

The French drugmaker said the vaccine it agreed to develop with Johnson & Johnson a year ago was “not sufficiently effective.

In 1994, in response to an E. coli outbreak linked to ground beef sold at Jack in the Box restaurants, FSIS established an E. coli sampling ...